The Genetic Landscape and Clinical Spectrum of Nephronophthisis and Related Ciliopathies
Overview
Authors
Affiliations
Nephronophthisis (NPH) is an autosomal-recessive ciliopathy representing one of the most frequent causes of kidney failure in childhood characterized by a broad clinical and genetic heterogeneity. Applied to one of the worldwide largest cohorts of patients with NPH, genetic analysis encompassing targeted and whole exome sequencing identified disease-causing variants in 600 patients from 496 families with a detection rate of 71%. Of 788 pathogenic variants, 40 known ciliopathy genes were identified. However, the majority of patients (53%) bore biallelic pathogenic variants in NPHP1. NPH-causing gene alterations affected all ciliary modules defined by structural and/or functional subdomains. Seventy six percent of these patients had progressed to kidney failure, of which 18% had an infantile form (under five years) and harbored variants affecting the Inversin compartment or intraflagellar transport complex A. Forty eight percent of patients showed a juvenile (5-15 years) and 34% a late-onset disease (over 15 years), the latter mostly carrying variants belonging to the Transition Zone module. Furthermore, while more than 85% of patients with an infantile form presented with extra-kidney manifestations, it only concerned half of juvenile and late onset cases. Eye involvement represented a predominant feature, followed by cerebellar hypoplasia and other brain abnormalities, liver and skeletal defects. The phenotypic variability was in a large part associated with mutation types, genes and corresponding ciliary modules with hypomorphic variants in ciliary genes playing a role in early steps of ciliogenesis associated with juvenile-to-late onset NPH forms. Thus, our data confirm a considerable proportion of late-onset NPH suggesting an underdiagnosis in adult chronic kidney disease.
Yang Y, Xue Z, Lai J, Zhang J, Pang C, Zhong J Clin Transl Med. 2025; 15(3):e70245.
PMID: 39995111 PMC: 11850762. DOI: 10.1002/ctm2.70245.
Utility of Genetic Testing in Adults with CKD: A Systematic Review and Meta-Analysis.
Schott C, Lebedeva V, Taylor C, Abumelha S, Roshanov P, Connaughton D Clin J Am Soc Nephrol. 2025; 20(1):101-115.
PMID: 39792540 PMC: 11737453. DOI: 10.2215/CJN.0000000000000564.
Sentell Z, Mougharbel L, Nurcombe Z, Babayeva S, Henein M, Chu L Hum Mol Genet. 2024; 34(4):368-380.
PMID: 39690811 PMC: 11811416. DOI: 10.1093/hmg/ddae182.
Olinger E, Wilson I, Orr S, Barroso-Gil M, Neatu R, Atan D Genet Med Open. 2024; 2:101834.
PMID: 39669628 PMC: 11613694. DOI: 10.1016/j.gimo.2024.101834.
Arai Y, Ito H, Shimizu T, Shimoda Y, Song D, Matsuo-Takasaki M Front Cell Dev Biol. 2024; 12:1370723.
PMID: 38989059 PMC: 11233770. DOI: 10.3389/fcell.2024.1370723.